Singapore mass-produces sterile male mosquitoes to combat dengue fever

Singapore has launched a large-scale programme to breed and deploy millions of sterile male mosquitoes in its ongoing battle against dengue fever, one of the region's most persistent public health challenges. The initiative involves raising genetically modified Aedes aegypti mosquitoes—the primary vector for dengue transmission—in specially designed facilities before their release into targeted neighbourhoods.

The approach, known as the sterile insect technique, works by introducing sterilized males into wild populations. When these males mate with females in nature, they produce no viable offspring, gradually reducing mosquito numbers without requiring widespread pesticide use. Singapore's health and environmental authorities have identified this method as a potentially more sustainable complement to traditional vector control measures.

The programme has been expanded significantly in recent years as dengue cases continue to surge across Southeast Asia. By producing males rather than females—which do not bite and thus do not transmit disease—researchers can focus efforts on population suppression rather than direct insect elimination. The breeding facilities maintain stringent quality controls to ensure the released mosquitoes meet scientific specifications.

Official statements indicate the initiative represents a shift toward innovation-driven public health solutions amid growing resistance to conventional insecticides. Early results from trial areas have shown measurable reductions in dengue-carrying mosquito populations, though health officials emphasize the strategy works most effectively when integrated with other prevention methods including community awareness campaigns and environmental management.